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Abstract
The increasing applicability of antifungal treatments, the limited range of available drug clas-
ses and the emergence of drug resistance in Candida spp. suggest the need for new treat-
ment options. To explore the applicability of C. albicans photoinactivation, we examined
nine structurally different imidazoacridinone derivatives as photosensitizing agents. The
most effective derivatives showed a >104-fold reduction of viable cell numbers. The fungi-
cidal action of the three most active compounds was compared at different radiant powers
(3.5 to 63 mW/cm2), and this analysis indicated that 7 mW/cm2 was the most efficient. The
intracellular accumulation of these compounds in fungal cells correlated with the fungicidal
activity of all 9 derivatives. The lack of effect of verapamil, an inhibitor targeting Candida
ABC efflux pumps, suggests that these imidazoacridinones are not substrates for ABC
transporters. Thus, unlike azoles, a major class of antifungals used against Candida, ABC
transporter-mediated resistance is unlikely. Electron paramagnetic resonance (EPR)-spin
trapping data suggested that the fungicidal light-induced action of these derivatives might
depend on the production of superoxide anion. The highest generation rate of superoxide
anion was observed for 1330H, 1610H, and 1611. Singlet oxygen production was also de-
tected upon the irradiation of imidazoacridinone derivatives with UV laser light, with a low to
moderate yield, depending on the type of compound. Thus, imidazoacridinone derivatives
examined in the present study might act via mixed type I/type II photodynamic mechanism.
The presented data indicate lack of direct correlation between the structures of studied imi-
dazoacridinones, cell killing ability, and ROS production. However, we showed for the first
time that for imidazoacridinones not only intracellular accumulation is necessary prerequi-
site of lethal photosensitization of C. albicans, but also localization within particular cellular
structures. Our findings present IA derivatives as efficient antifungal photosensitizers with a
potential to be used in local treatment of Candida infection.
PLOS ONE | DOI:10.1371/journal.pone.0129301 June 8, 2015 1 / 19
OPEN ACCESS
Citation: Taraszkiewicz A, Szewczyk G, Sarna T,
Bielawski KP, Nakonieczna J (2015) Photodynamic
Inactivation of Candida albicans with
Imidazoacridinones: Influence of Irradiance,
Photosensitizer Uptake and Reactive Oxygen
Species Generation. PLoS ONE 10(6): e0129301.
doi:10.1371/journal.pone.0129301
Academic Editor: Michael Hamblin, Massachusetts
General Hospital, UNITED STATES
Received: December 21, 2014
Accepted: May 8, 2015
Published: June 8, 2015
Copyright: © 2015 Taraszkiewicz et al. This is an
open access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: Financial support for this work was
obtained from the National Science Center grant no:
NCN 2013/09/B/NZ7.00410 (JN), 2011/03/B/NZ1/
00007 (TS), and NCN 2013/09/N/NZ1/00188 (AT). AT
is supported by LiSMIDoS – Life Sciences and
Mathematics Interdisciplinary Doctoral Studies. The
funders had no role in study design, data collection
and analysis, decision to publish, or preparation of
the manuscript.
Introduction
Due to longer life span and increasing numbers of people with compromised immune systems,
the number of fungal infections caused by yeasts has significantly increased in recent years[1].
This phenomenon is also related to a dramatic increase in antifungal drug resistance. The new-
est classes of antifungals (e.g., triazoles and echinocandins) are widely used and effective, how-
ever, optimal therapy may be complicated through emergence of at least four resistance
mechanisms, the most prominent being the induction of efflux pumps leading to low drug con-
centration [2]. Antimicrobial agents that can be activated with light are commonly known as
photoantimicrobials [3]. In the presence of oxygen, these agents use the energy of visible light
to produce highly reactive oxygen species, e.g., singlet oxygen or hydroxyl radicals, which are
toxic to microbial cells. The process is known as antimicrobial photodynamic inactivation
(PDI). The main advantage of photoantimicrobial agents, also known as photosensitizers, over
classical antimicrobials is the multiple-target actions of these compounds. Reactive oxygen spe-
cies, as long as they are localized in the close vicinity of a specific molecular target, act on pro-
teins, nucleic acids or unsaturated lipids. As a consequence, photoantimicrobials are relatively
immune to individual resistance mechanisms, and can act effectively against wild-type and an-
tifungal-resistant isolates. Indeed, there has been no reports indicating the in vitro induction of
resistance to the action of light-dependent drugs [4–6]. Due to their short life times, reactive
oxygen species act locally. The selectivity issue remains a concern, particularly in the case of
yeast cells (i.e., eukaryotic pathogens), but the potential ‘therapeutic window’ although more
narrow compared with bacterial cells, is still possible to obtain [7–8]. Photoantimicrobials are
only active after light treatment, thus localized skin and soft tissue infections caused by fungi
are good targets for PDI. Thus, this treatment assures the selectivity and minimization of the
side effects.
The fluence of light has been, for years, considered the most important parameter in photo-
dynamic action against microbial cells, based on the reciprocity principle [9]. However, some
well documented reports exist pointing to the importance of the time parameter over which
the light is being delivered to cells [10]. Influence of two fluence rates of light (artificial or
solar) on the efficiency of photoinactivation was studied in the past with the use of cationic
porphyrins, where it was demonstrated that under 620 W/m2 of solar light, photoinactivation
of bioluminescent E. coli was faster over artificial 40 W/m2 due to higher light fluence rate [11].
The effect of light source, light dose, fluence rate was also shown to be of critical meaning for
phage photoinactivation in a extensive studies using light sources within range of 40 W/m2–
1690 W/m2[12].The finding that fluence rate and exposure time play important role in effec-
tiveness of antimicrobial PDI is of profound meaning and opens the possibility to optimize
irradiation protocols for in vivo studies.
Candida spp. plays a major role in localized and systemic infections in humans. The fungal
infections are particularly risky for a growing number of immune-compromised, and post-
trauma patients, individuals with tumours and those who underwent surgical interventions.
Candida albicans is most frequently isolated fungi species from infections [13].
Several studies on planktonic and biofilm forms of C. albicans culture have shown effective
killing using various photosensitizing compounds, including phenothiazinium photosensitizers
[7,14–16], phthalocyanines[17] and porphyrins[18–24]. Antifungal PDI research is currently
at the stage of ex vivo experiments, i.e., using yeast cell cultures, rather than infected animal
models. However, some in vivo studies on animal models of human infections demonstrated
the potential of PDI in eradicating pathogenic fungi. Indeed, a significant decrease in the num-
ber of viable C. albicans cells was observed following PDI in rat model of oral candidiasis using
a hematoporphyrin derivative[25] or methylene blue[26].However, the complete elimination
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of viable cells was not achieved. In other studies, antifungal PDI was shown to reduce micro-
scopic lesions of experimentally induced candidiasis in rats and inhibit the proteinase activity
of C. albicans. Albeit, a reduction in the number of viable cells was not achieved[27,28]. The ad-
equate efficacy of a new methylene blue-based PDI was also established for a cutaneous skin in-
fection[29] in rat model of skin burn wound infections[30], and in C. albicans-induced murine
vaginitis[31]. Thus, despite considerable progress, antifungal PDI remains at the stage of devel-
opment, and in particular, the effective killing of pathogen cells remains a challenge. Therefore,
there is a need for the development of new and improved photoantimicrobials, and the exami-
nation of the mechanism underlying actions of these compounds.
The objective of the present study were therefore:(i) to investigate the irradiance-dependent
efficacy of C. albicans photoinactivation with the use of imidazoacridinone derivatives, (ii) to
study cellular accumulation of these derivatives, and the type of reactive oxygen species pro-
duced during the photodynamic process.
Materials and Methods
Strains
Candida albicans Quality Control strains were used: ATTC 10231, ATCC 90028, and ATCC
14053. For photoinactivation studies and imidazoacridinone accumulation experiments, the
yeast cells were grown overnight in BHI medium (Brain Heart Infusion) with shaking (37°C,
150 rpm). ATCC strain 10231 was used in photoinactivation experiments (impact of variable
irradiant power under a fixed light dose), and examining imidazoacridinone accumulation,
and apoptosis induction. The latter two strains, ATCC 90028 and ATCC 14053were used in ac-
cumulation studies, and we also assessed the reduction of survival for these two strains under
particular illumination conditions: 20J/cm2, 7mW/cm2).
Chemicals
The basic forms of three imidazoacridinone derivatives (IA), namely 1330, 1415, and 1558
were obtained from A. Skladanowski of Gdansk University of Technology, Poland. These com-
pounds were prepared according to the method described previously [32–36]. Compounds
1610 and 1611 were synthesized according the same method as IA described above [32–36].
The hydrochloride form of the following imidazoacridinone derivatives, namely 1330H,
1415H, 1558H, and 1610H were prepared using the same protocol, and subsequently converted
into hydrochloride salts using the following procedure: a slight molar excess of hydrogen chlo-
ride in absolute ethyl ether was added dropwise to the compound solution in the mixture of
chloroform:methanol, at temperature 5°C. The yellow-orange solid was precipitated using an-
hydrous ethyl ether, followed by separation and crystalization with the ethyl ether. The general
structure of the compounds used in the study is presented in Fig 1. The compounds were first
dissolved in pure (100%) DMSO (Sigma-Aldrich, Germany) to obtain 10 mM stock solutions,
and stored at -20°C until further used.All other chemicals were of analytical grade, including
meso-Tetra(N-methyl-4-pyridyl)porphinetetratiosylate (TMPyP) (Sigma-Aldrich, Germany);
Verapamil (Sigma-Aldrich, Germany); 5,5-Dimethyl-1-pyroline N-oxide (DMPO)(Sigma-Al-
drich, Germany).
Antimicrobial photodynamic studies on C. albicans
Candida albicans was grown overnight in standard BHI (Brain Heart Infusion) medium
(Biomerieux, France) at 37°C, with shaking (150 rpm). C. albicans standardized suspension in
BHI (5x106 CFU/ml) was prepared and added to the wells on sterile 96 well flat-bottom
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microtiterplate. The studied concentrations (50 or 100 μM) of each photosensitizer imidazoa-
cridinone derivative were added. The plate was incubated in the dark at 37°C for 30 min with-
out shaking and the samples were irradiated (LED illuminator, output power of 11W/12mm2,
blue light of 405 nm, custom designed for laboratory use(Secure Media, Poland). After irradia-
tion serial dilutions were obtained from every sample in sterile PBS and 10 μl aliquots were
spotted on BHI agar plates. The plates were incubated overnight at 37°C and the colony form-
ing units (CFU) were counted and the results were statistically analysed. Three types of con-
trols were included in the photoinactivation experiment: (i) cells treated with light only, (ii)
cells incubated in the dark in the presence of imidazoacridinone derivatives, and (iii) cells incu-
bated in the dark in the absence of imidazoacridinones. Each experiment was performed as a
separate biological replicate from cultures grown independently.
Accumulation of photosensitizers in C. albicans
Standardized suspensionsof C. albicans were prepared in PBS (106 CFU/ml) from overnight
grown independent cultures in BHI (Brain Heart Infusion) medium (Biomerieux, France).
Each assay was performed as a separate biological replicate of the experiment. Photosensitizers
(IAs) were added at concentrations of 50 and 100 μMto 1 ml of C. albicans suspension. The
samples were incubated in the dark at 37°C for the 30 min without shaking. Samples were cen-
trifuged at room temperature for 5 mins, at 5000 rpm (2.3xg), and supernatant was
Fig 1. Chemical structures of imidazoacridinone derivatives.
doi:10.1371/journal.pone.0129301.g001
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spectrophotometrically analysed to determine the amount of photosensitizer remaining out-
side the cells. The imidazoacridinone concentrations were calculated based on the Lambert-
Beer law and the extinction coefficient values were experimentally measured for each com-
pound. The concentrations of accumulated imidazoacridinone in these cells were obtained
after subtracting the calculated concentration of imidazoacridinone present in the supernatant
from the concentration used for cell incubation (50 or 100 μM). These values are presented in
Table 1 (IAs accumulated in cells). Subsequently, the cells were centrifuged at room temp for
5 mins, at 5000 rpm (2.3xg), re-suspended in PBS, and further incubated in the dark at 37°C
for 30 min without shaking. The cells were subsequently pelleted (5 min, 5000 rpm [2.3xg],
room temp.),and absorbance of the supernatants was analysed to determine the amount of the
photosensitizers transported out of the cells (Table 1, IAs remained after washing). The absorp-
tion measurements were performed on the Beckman DU-640 Spectrophotometer at 420 nm.
To measure imidazoacridinones accumulation in the presence of verapamil, the cells (5 McFar-
land, 106CFU/ml) were centrifuged at room temp for 5 mins, at 5000 rpm (2.3xg), washed with
PBS, incubated with 200 μM verapamil, and subsequently, without further washing, incubated
with each imidazoacridinone derivative. the cells were then pelleted under the above conditions
and the absorbance of the supernatants was measured.
Imidazoaridinone derivatives fluorescence was observed using fluorescent microscopy. The
cells (106 CFU/mL) were harvested at room temp for 5 mins, at 5000 rpm (2.3xg), washed with
PBS, and incubated with 50 μM of imidazoacridinone suspension. Subsequently, the cells were
placed ontoa cohesive microscopic slide, covered with a glass coverslip and observed under
fluorescent microscopy at an excitation of 360–370 nm, and emission of>420 nm (Olympus
BX51 fluorescence microscope with F-View-II CCD camera). The measurements and image
analysis were conducted using AnalySIS software.
Table 1. Accumulation and phototoxic effect of imidazoacridinones inCandida albicansATCC 10231 strain.
IAs Initial IAs conc. 50 μM = 0.05 μmol/106 cells Initial IAs conc. 100 μM = 0.1 μmol/106 cells PDI effect (20 J/cm2,
7 mW/ cm2)
IAs accumulated in
cellsa
IAs remained after
washinga
IAs accumulated in
cellsa
IAs remained after
washinga
50 μM
IA
100 μM
IA
μmol/106 cells ± SD μmol/106 cells ± SD Reduction in
survival [log10 units
CFU/ml]b,c,d
1330 0.033 ± 0.002 0.023 ± 0.002 0.076 ± 0.004 0.064 ± 0.0067 2 ± 0.03 >5 ± 0.00
1415 0.023 ± 0.002 0.013 ± 0.002 0.054 ± 0.006 0.036 ± 0.0066 1 ± 0.1 1 ± 0.1
1558 0.031 ± 0.001 0.020 ± 0.005 0.065 ± 0.010 0.048 ± 0.0119 0 ± 0.5 2 ± 0.1
1330h 0.042 ± 0.001 0.032 ± 0.007 0.086 ± 0.001 0.077 ± 0.0048 1 ± 0.22 2 ± 0.19
1415h 0.019 ± 0.002 0.006 ± 0.002 0.042 ± 0.002 0.024 ± 0.0036 1 ± 0.13 1.5 ± 0.22
1558h 0.024 ± 0.002 0.010 ± 0.004 0.049 ±0.004 0.026 ± 0.0065 0 ± 0.65 1 ± 0.12
1610 0.036 ± 0.002 0.023 ± 0.003 0.065 ± 0.004 0.046 ± 0.0055 1 ± 0.00 2.5 ± 0.00
1610h 0.035 ± 0.004 0.026 ± 0.011 0.063 ± 0.003 0.044 ± 0.0062 1 ± 0.55 2 ± 0.11
1611 0.011 ± 0.002 0.013 ± 0.010 0.028 ± 0.004 0.022 ± 0.0047 0 ± 0.80 0 ± 0.07
IAs—imidazoacridinone derivatives; PDI—antifungal photodynamic effect, The values were calculated by subtracting log10 CFU/ml of tested samples from
those of untreated controls (0 J/cm2; 0 μM IA). At least three biological replicates were used for calculation of the mean reduction values.
amean values of three replicates ± standard deviation of the mean
bin samples incubated in the dark without imidazoacridinone derivatives, the number of C. albicans cells was c.a. 5x106 CFU/ml
cin the samples incubated in the dark with 50 μM or 100 μM of each imidazoacridinone derivative, the number of cells was c.a. 5x106 CFU/ml
din the samples exposed to light only (20J/cm2, 7mW/cm2), the number of C. albicans cells was c.a. 5x106 CFU/ml
doi:10.1371/journal.pone.0129301.t001
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Time-resolved spectroscopic detection of singlet oxygen -1O2
Time-resolved luminescence of 1O2 was measured at 1270 nm. Solutions of imidazoacridi-
nones (100 μM) in 1-cm fluorescence cuvettes (QA-1000, HelmaOptik) were excited with 355
nm microjoule pulses (750 ps duration) generated using a microchip Nd:YAG laser (Pulselas-
P-1064-FC, Alphalas GmbH, Germany) operating with a 2–10 kHz repetition rate. To filter
out the first and third harmonics of laser radiation, 50-cm water filter and dichroic mirrors
(BK7series, Eksma Optics, Lithuania) were used. Near-infrared luminescence was measured
perpendicularly to the excitation beam in a photon counting mode using a thermoelectric
cooled NIR PMT module (Model H10330-45, Hamamatsu, Japan) equipped with 1100-nm
cutoff filter and additional selected narrow-band filters (NB series, NDC Infrared Engineering
LTD, UK). A computer-mounted PCI-board multichannel scaler was used (NanoHarp 250,
PicoQuant GmbH, Germany), and the data collection was synchronized with laser pulses using
an ultrafast photodiode (UGP-300-SP, Alphalas GmbH, Germany) as a trigger. First-order lu-
minescence decay fitting was achieved using the Levenberg-Marquardt algorithm in custom-
written software. Each measurement of singlet oxygen phosphorescence was repeated three
times on independent samples.
Detection of oxygen radicals through Electron Paramagnetic Resonanse
spin trapping
EPR spin-trapping was employed using DMPO as a spin trap at concentrations of 10 mM.
Samples of imidazoacridinone derivatives (100 μM each) were irradiated in EPR quartz flat
cells in the resonant cavity with blue light (70 mW/cm2) derived from a 300 W high pressure
compact arc xenon lamp (Cermax, PE300CE–13FM/Module300W, Perkin-Elmer) equipped
with a water filter, heat reflecting hot mirror, cutoff filter blocking light below 390 nm, and di-
chroic filter transmitting light at a range of 400–500 nm. The EPR samples were run using a
microwavepower of 10.55 mW, modulation amplitude of 0.05 mT, scan width 8 mT, and a
scan time of 80 s, while the kinetics measurements were obtained at an overmodulated ampli-
tude (0.2 mT).The EPR measurements were performed using a BrukerEMX–AA EPR spec-
trometer (BrukerBioSpin, Germany). Simulations of EPR spectra were performed
usingWinSIM (Version 0.98) software. TheEPR spin trapping measurements were carried out
using three independent samples yielding with very similar results.
Statistical analysis
Each experiment was performed at least in triplicate. The primary data are presented as the
means with standard deviations of the mean. The statistical analysis was performed using one-
way analysis of variance (ANOVA) with Tukey’s post-hoc test. The hypotheses were tested at a
significance level of 0.05. All analyses were performed using the STATISTICA version 8.0 soft-
ware (StatSoft Inc. 2008, data analysis software system, Tulsa, USA).
Results
Irradiance influences the antifungal PDI outcome
We first examined the impact of variable irradiant power under a fixed light dose. Hence, the
time of irradiation was accordingly varied, testing 3 different most active imidazoacridinone
derivatives, 1330, 1558 and 1610H and measuring the survival of yeasts cells. The total dose of
light applied was 20 J/cm2, and the dose rate varied at 3.5, 7, 15, 30, and 63 mW/cm2. The re-
sults indicated a non-linear correlation between the applied power density and cell killing. Nei-
ther the highest applied power density (of 63 mW/cm2, the shortest exposure time), nor the
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lowest power density(3.5mW/cm2, the longest irradiation time)were effective. The best results
were obtained at medium irradiance (7 mW/cm2) and hence, at a medium irradiation time
(Fig 2). A similar pattern of medium irradiance being most active in photokilling, was observed
at a higher light dose (30 J/cm2; Fig 2). However, a dose rate of7 mW/cm2 was the most effec-
tive in 1330 and 1610H activation, whereas 15 mW/cm2 was the most efficient in case of 1558
activation. The compound 1330 was previously photoactivated at a lower light dose of 20
J/cm2, so that further increase to 30 J/cm2 had no significant effect on photokilling. However,
for the remaining 2 compounds, 1558 and 1610H, the higher light dose applied exerted im-
proved killing efficacy, reaching 5 log10 units of killing at 30 J/cm
2 versus only 2 log10 units at
20 J/cm2 as observed for 1558 (15 mW/cm2). A similar tendency was observed for 1610H, al-
though the differences at 7 mW/cm2 between optimal photokilling with a total light dose of 30
J/cm2 versus 20 J/cm2 were not so explicitly pronounced: 3.5 log10 units of killing and 3 log10
units of killing, respectively (Fig 2). Overall, we observed that, beyond the light dose itself, the
time of exposure, and hence the irradiation power is a critical determinant of the effectiveness
of antimicrobial photoinactivation.
Imidazoacridinones accumulation in Candida albicans
We examined 3 ATCC reference strains of C. albicans (10231, 90028, and 14053) to quantify
the amounts of photosensitizers that accumulated within these cells. We applied the spectro-
photometric measurements, as described in Materials and Methods. We observed no signifi-
cant differences in the accumulation profiles among the studied strains with respect to the
examined imidazoacridinone derivative (Table 1, S1–S2 Tables). Therefore the next analysis fo-
cused on C. albicans strain 10231.
The quantity of imidazoacridinones accumulated in C. albicans strain 10231 after incuba-
tion with 50 μM (0.050 nmol/106 cells) of the tested compounds ranged from 0.015 to 0.042
nmol/106 cells (Table 1). Compound 1611 was an exception, exhibiting the lowest value of ac-
cumulation (0.01 nmol/106 cells). This low accumulation level correlated with a lack of the
phototoxic activity at both 50 and 100 μM concentrations tested (Table 1). The compounds, re-
sulting in the highest photokilling, namely 1330, 1330H, 1558, 1610 and 1610H, accumulated
most effectively (more than 60% of initial concentration used). Moreover, for the most photo-
active compounds, the amount remaining within the cells after washing with PBS, was> 70%
of the initially accumulated amount. Notably, 1611, which did not exhibit any phototoxic activ-
ity, accumulated in C. albicans cells only at 20%, and this level remained unchanged after
PBS washing.
We next examined the accumulation of the applied imidazoacridinone derivatives in C. albi-
cans strain 10231 using fluorescent microscopy. The optimal imidazoacridinones concentra-
tion and time of incubation in the dark were selected based on previous studies [37]. The
fluorescent microscope images (Fig 3), revealed quantitative differences in accumulation and
the distribution pattern inside the cells. For example, after 30 min of incubation, 1330H was
observed inside the cell, with the highest concentration detected within the subcellular mem-
brane fraction. This trend was similar with 1558H, 1610, and 1610H. The remaining two deriv-
atives, namely 1611 and 1415H, accumulated poorly compared with the four above mentioned
compounds, and showed a more peripheral distribution. A completely different pattern of in-
tracellular distribution was observed for 1330. In this case, the signal corresponded with small,
explicit fluorescing points distributed inside the cell (Fig 3).
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Fig 2. Survival ofCandida albicansATCC 10231 cells after photodynamic treatment with various irradiance power and imidazoacridinone
derivatives. Three representative imidazoacridinone derivatives are shown here: a. 1330, b. 1558, and c. 1610H. The cells were incubated with the following
concentrations of each imidazoacridinone derivative: 0, 50, and 100 μM. Following incubation, a total light dose (LED light 405 nm) of 20 J/cm2 (left panel) or
30 J/cm2 (right panel) was applied, at various irradiance power as indicated on the X-axis. The value of ‘0 mW’ represents control experiments, i.e., cells
incubated in the dark in the absence (0 μM) or presence (50 μM or 100 μM) of IA derivative, and not subjected to illumination. The remaining values of ‘3.5
mW’ up to ‘63 mW’ represent the light-treated samples at a given irradiance. The statistical significance of the reduction in survival was calculated for each
IA-treated sample with respect to the light only treated samples (black bars). The number of surviving cells presented on the Y-axis represents the mean
value of three independent biological replicates, and the error bars represent the standard deviation. *, significant at the level of P value of < 0.05.
doi:10.1371/journal.pone.0129301.g002
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Verapamil inhibits imidazoacridinone accumulation
We determined whether the ABC transporters in C. albicans recognized the newly applied IAs,
and whether resistance to PDI based on these photosensitizers might occur. To this end, we
pre-treated C. albicans with verapamil (200μM), a potent ABC pump inhibitor, and subse-
quently measured the levels of IA accumulation. The results, presented in Fig 4, indicated a de-
crease in IAs accumulation after verapamil pre-treatment, consistent with free diffusion rather
than active transport. We also observed differences between the overall accumulation levels
and accumulation in the presence of verapamil with respect to particular compounds. Verapa-
mil had negligible effect on the most effectively accumulated compounds (1330 and 1330H; the
estimated decrease in accumulation in the presence of verapamil accounted for 15% and 8%,
respectively compared with the amount accumulated in the absence of verapamil). In case of
1415, 1558, 1610, and 1610H verapamil pre-treatment had a more noticeable effect (30% de-
crease in accumulation with respect to non-verapamil treated samples). The highest decrease
in accumulation after verapamil treatment was observed for 1415H and 1558H (> 60%). The
effect was apparent for 1611, as yeast cells accumulated a low amount of this compound and
verapamil had no visible effect on this process (Fig 4).
Fig 3. Accumulation of imidazoacridinone derivatives inCandida albicansATCC 10231 cells. The cells were incubated in the dark with the denoted
imidazoacridinone derivatives (50 μM, 30 min, 37°C). Imidazoacridinone fluorescence (right panel) was observed under a fluorescence microscope
(excitation wavelength 360–370 nm, emission >420 nm). The same cells visualized under white light are presented in the left panel.
doi:10.1371/journal.pone.0129301.g003
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Photochemistry of imidazoacridinones in model systems
We used two experimental approaches to determine the type of photochemical processes medi-
ated through imidazoacridinones in simple model systems. The approaches included: near-in-
frared time-resolved luminescence, a direct method to monitor the formation and decay of
singlet oxygen (1O2), and EPR-spin trapping, an indirect method for detecting short-lived free
radicals. It is important to emphasize that EPR-spin trapping is a canonical method for study-
ing oxygen radicals formed during type I photosensitized oxidation reactions.
Quantum yields for singlet oxygen photogeneration through IAs were determined by mea-
suring time-resolved luminescence in acetonitrile solutions at 1270 nm, after excitation of the
studied compounds with 355 nm laser light. Rose Bengal was used as a reference, following ex-
citation at 355 nm. The photoexcitation of IAs resulted in singlet oxygen generation (Fig 5), ev-
ident by the observed dependence of the intensities of the time-resolved luminescence signals
on oxygen presence in the samples studied and wavelength at which the signals were detected.
Importantly, the corresponding quantum yields varied from low (2%) for 1610 to moderate
(16%) for 1330H compared with the well known efficient singlet oxygen generators Rose Ben-
gal (70%) and TMPyP (75%). Electron paramagnetic resonance (EPR)-spin trapping using
5,5-dimethyl-1-pyrroline N-oxide (DMPO) as a spin trap, revealed the photogeneration of su-
peroxide anions (O2 _ˉ) through all imidazoacridinones (using as solvent DMSO:H2O, at 9:1
ratio). Fig 6 shows the exemplary spectra of the DMPO spin adduct after the photoexcitation
Fig 4. Accumulation of imidazoacridinone derivatives inCandida albicansATCC 10231 cells in the presence of verapamil. The cells (106 CFU/ml)
were incubated with 50 μM of a particular imidazoacridinone derivative (indicated on the X-axis) in the dark, and the accumulation was measured through
spectrophotometry as described in Materials and Methods (black bars). The cells treated as described, but pretreated with 200 μM of verapamil before
incubation with the imidazoacridinone derivative, are represented with grey bars. The mean values from three independent biological experiments are
shown and the error bars represent the standard deviation.*, significant at the level of P value of < 0.05.
doi:10.1371/journal.pone.0129301.g004
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of 1330 compound in the presence and absence of reduced nicotinamide adenine dinucleotide
(NADH). The simulated spectrum of the DMPO spin adduct using superoxide anion is shown
in the inset of Fig 6. Comparison of the simulated and experimental spectra indicates that 1330
produces superoxide anion upon excitation with UV light (355 nm) and the photoformation of
the O2 _ˉsignal is enhanced by about seventy-fold in the presence of an electron donor such as
NADH. Similar spectra were recorded for all the remaining imidazoacridinone derivatives.
The accumulation of the DMPO spin adduct as a function of irradiation time for derivative
1330, in the presence and in the absence of NADH, is shown in Fig 7A. These data indicate
that the relative rates of spin adduct formation can be calculated with respect to riboflavin (a
reference superoxide anion generator). Such measurements performed for different imidazoa-
cridinones indicate that the rate of superoxide anion photoformation is 30–60 times lower
than that of riboflavin (Fig 7B). Notably, one of the highest rates of superoxide radical genera-
tion was observed with 1611.
Notably, the rate of O2 _ˉgeneration was dramatically increased for all tested imidazoacridi-
nones when NADH was included in the reaction mixture. The observed acceleration of O2 _ˉ
generation in the presence of NADH, varied among the studied compounds. The highest en-
hancement of the rate of superoxide anion photoformation (~140-fold) was observed for
1330H, 1610H, and 1611, while the lowest rate was detected for 1610(~30-fold).
Discussion
The apparent increase in a number of studies on C. albicans reflects two phenomena: the grow-
ing number of isolates resistant to the currently applied antifungals, and, the increasing num-
ber of patients with local candidiasis symptoms alongside the growing number of neutropenic,
immune-compromised patients [38]. Thus, antifungal photodynamic therapy can be consid-
ered as an alternative promising strategy to control localized C. albicans infections [18,39]. No-
tably, although encouraging data on photoinactivation of Candida spp. have been published,
Fig 5. Singlet oxygen generation through imidazoacridinone derivatives. Time-resolved luminescence
of singlet oxygen (1O2) was measured at 1270 nm. The excitation wavelength used was 355 nm. Rose
Bengal, anthracene, and TMPyP were used as standards with known singlet oxygen quantum yields. The Y-
axis represents the quantum yield of singlet oxygen generation, where a maximal value of 100% indicates
that the entire energy of triplet state is transformed into a singlet excited state of molecular oxygen. The
quantum yields are determined within +/- 5% accuracy.
doi:10.1371/journal.pone.0129301.g005
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there are only few reports concerning the characterization and/or mechanism of action of new
photosensitizers. Here, we addressed photosensitizer cellular accumulation, the nature of gen-
erated reactive oxygen species, and light-induced photosensitizers activation. These aspects of
photodynamic therapy are important, particularly regarding the potential clinical applications
of antifungal PDI.
Porphyrins and phenothaziniums were the first compounds shown to be effective in the
photosensitization of C. albicans cells in suspension [7,20]. These results were later confirmed
in mouse models of local Candida infections [25,26] observing antifungal effects, including
strains that were azole-resistant[40]. However, due to the variability in experimental parame-
ters, the comparison of outcomes from different studies is difficult. When analysing photo-
chemical and photobiological phenomena, fluence (the energy delivered per unit area) is a key
radiation parameter to quantitatively characterize the observable effects. According to the
Bunsen-Roscoe law (the reciprocity rule), the observable effect is directly proportional to the
total radiation energy dose, irrespective of the administered regime[9]. However, it has been
demonstrated that certain photobiological reactions critically depend on the fluence rate
(power of radiation per unit area incident on a surface)[9]. Accordingly, Henderson et al.
showed that low fluence rate significantly decreases the number of clonogenic cells, while an
insignificant reduction was observed following the high fluence rate treatment of tumour cells
with Photofrin [41]. A similar trend was also observed in the present study (Fig 2). The efficacy
Fig 6. A representative single Electron Paramagnetic Resonance (EPR) spectrum obtained upon photoexcitation of imidazoacridione derivative
1330. The predicted (inlet) and experimental spectra of photoexcited imidazoacridinone 1330 in a DMSO/DMPOmixture, upon exposure to light at a
wavelength range of 540–740 nm are shown.
doi:10.1371/journal.pone.0129301.g006
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of photodynamic therapy could therefore be significantly increased through modifications in
the irradiation protocol. The fact that fluence rates affect imidazoacridinone-mediated photo-
dynamic treatment, may be considered as a valuable means of increasing the selectivity of pho-
totherapy. Recent data, and the results published by another group using methylene blue [10]
indicate that output power and/or time of exposure should be considered as important deter-
minants of the photokilling of yeast cells. Similar conclusions can be drawn based on sewage
bacteriophage inactivation with cationic porphyrins [12]. Although different molecular and
cellular mechanisms could be responsible for the observed effects, oxygen depletion induced
through photosensitized reactions, might play an important role. It is conceivable that oxygen
photouptake at higher fluence rates exceeds oxygen replenishment due to its diffusion from
Fig 7. Electron Paramagnetic Resonance (EPR)-spin trapping experiments. a. An example of an EPR spectrum of superoxide anion created upon
photoexcitation of imidazoacridinone 1330 alone and in the presence of NADH. b. Comparison of the coefficient a indicating the efficiency in superoxide
anion creation derived from the EPR spectra of different irradiated imidazoacridinone derivatives (indicated in X-axis) in the presence and absence of NADH.
Riboflavin was used as a positive control photosensitizer that efficiently generates superoxide anion in the absence of NADH.
doi:10.1371/journal.pone.0129301.g007
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oxygen rich surroundings. As a result, the efficiency of photodynamic cell killing will decrease
at higher fluence rates.
In our previous work on 1330, we did initial experiments concerning photo- and cytotoxici-
ty of this compound towards human HaCaT cells. We observed that 200J/cm2 of 380–480 nm
light only treatment causes about 25% decrease in the survival of human HaCaT cell line with
respect to non-light treated cells [37]. This indicates certain degree of light only toxicity, how-
ever, still at an acceptable level. With the following PDI treatment conditions: 200J/cm2, 50 μM
of 1330 compound, we obtained satisfactory therapeutic window (3.1 log10 decrease in C. albi-
cans cells survival, and 43% decrease in HaCaT cell line survival), which points out that C1330
may potentially be used as a candidate photosensitizer in the light-dependent killing of C.
albicans cells.
Another key factor is the photosensitizer used. Employing different imidazoacridinone de-
rivatives, we have shown that fast intake and slow clearance from the treated yeast is a crucial
parameter. Indeed, the best derivatives, in terms of PDI efficacy, could be detected within the
treated cells, even after prolonged incubation (up to 30 min). This observation is in contrast
with the previously studied cationic porphyrin TriP[4], which was slowly taken up and ineffi-
ciently accumulated by yeast cells. It has been suggested that membrane damage is responsible
for the killing of C. albicans(21). These authors also showed that vacuoles remained intact
during PDI treatment. Notably, imidazoacridinone accumulation can be easily reversed as
demonstrated after washing the cells with PBS, which decreased the observed imidazoacridi-
none-dependent phototoxicity. The data obtained here and particularly the lack of inhibition
by verapamil, suggested that imidazoacridinones are largely imported into cells via spontane-
ous diffusion through the membrane. In contrast to hypericin [42], where the photosensitizer
localized within a large intracellular patch, most likely within a vacuole, imidazoacridinones lo-
calized in other cytosolic organelles with the vacuole remaining unstained. Phthalocyanine
Pc4, another frequently used photosensitizer, was shown to localize in the mitochondria[43].
Our most active derivative, imidazoacridinone 1330, showed an intracellular accumulation pat-
tern, most likely in the cytoplasm. This unique pattern of intracellular distribution might be as-
sociated with a dramatic increase in lethality of photosensitized cells. The remaining IAs
exhibited a rather dispersed pattern of cytoplasmic distributions. A recent study on human
ovarian carcinoma cells treated with 3,6-bis(imidazolidine)acridine, which is structurally simi-
lar to imidazoacridinones, indicated that this compound primary localizes to lysosomes and
mitochondria, but not in the nuclei [44]. Similarly, the lysosomal localization of imidazoacridi-
nones was observed in human A549 cell line [45]. Therefore, it is likely that 1330 localizes in
Candida lysosomes, and this localization pattern results in highly effective lethal photosensiti-
zation (as further discussed below).
The key mechanism of drug resistance in C. albicans is the low intracellular accumulation of
antifungal agents due to elevated levels of drug efflux pumps such as ABC (ATP binding cas-
sette) transporters, primarily of CaCdr1p and CaCdr2p [46]. Following a genetic modification,
Candida albicans strains overexpressing ABC efflux pumps (CaCDR1/CaCDR2) resisted meth-
ylene blue-mediated photodynamic action [47]. Photosensitizers comprising substrates for
ABC-type transporters therefore have limited efficacy for antifungal photodynamic treatment
[47]. As shown here, imidazoacridinones are not substrates for ABC transporters, as indicated
by the lack of verapamil inhibition, which blocks the cellular efflux pump CaCDR1. The ob-
served decrease in imidazoacridinones accumulation in C. albicansmight reflect either the dis-
turbed uptake of these compounds in the presence of verapamil or CaCDR1-independent
leakage. The observed differences in accumulation profiles of particular imidazoacridinones in
the presence and in the absence of verapamil are relatively small, and might therefore reflect
the multi-effect action of verapamil on yeast cells. CaCDR1 transporters have been implicated
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in multiple functions, including the transport of inorganic ions, efflux of steroids, and phos-
pholipid translocation. These mechanisms might indirectly contribute to the small differences
observed in the absence and presence of verapamil [48]. Taken together, CaCDR1 is unlikely to
expel the studied imidazoacridinones.
The first step in photodynamic action is light absorption by a photosensitizer. In the pres-
ence of oxygen, excited photosensitizers act according to two processes: type I and/or type II.
As a result of electron transfer, radical species are generated (type I); however, energy transfer
between the excited triplet state of the photosensitizer molecule and the ground state molecular
oxygen leads to the formation of singlet molecular oxygen (type II). Both types of reactive oxy-
gen species: oxidizing radicals and singlet oxygen, react with DNA, proteins, lipids or other cel-
lular biomolecules. In various photodynamic phenomena, singlet oxygen is typically
considered as the reactive oxygen species responsible for critical cellular damage [49]. The pro-
duction of singlet oxygen is important in PDI, as there are no known resistance mechanisms
for the detoxification of this compound [18]. The quantum yield of singlet oxygen production
upon the photoexcitation of imidazoacridinone derivatives was low compared with the known
efficient producers of singlet oxygen, such as TMPyP or Rose Bengal photosensitizers (Fig 5).
However, even the relatively inefficient production of singlet oxygen could have significant bio-
logical impact when this species is generated in proximity to molecular targets that readily un-
dergo oxidative modifications [50–51]. This phenomenon was observed in the case of 1330 and
1330H,which produced similar amounts of singlet oxygen, and showed similar levels of accu-
mulation in yeasts cells, but have different localization pattern. As a result, significant differ-
ences in the photokilling efficacy of these compounds were observed (Fig 3 and Table 1).
Although all imidazacridinones examined in the study produced 1O2, the yield of different
compounds varied, ranging from 2–16%. There was no obvious correlation between the effi-
ciency of singlet oxygen photogeneration and the photokilling efficacy of imidazoacridinones.
However, it should be emphasized that the luminescence signal of 1O2 might be affected by dif-
ferences in in vitro and in vivomodels, as shown for porphyrin XF73-based lethal photosensiti-
zation process [52]. Additionally, the potential role of free radicals in the photodynamic killing
of the yeast should be considered. The efficiency of the imidazoacridinones to photogenerate
superoxide anion is even lower than that of singlet oxygen. In the absence of electron donors,
such as NADH, the compounds photogenerate superoxide anion with at least ten-fold lower ef-
ficiency than riboflavin, which has quantum efficiency for such a process ~ 1% [53]. Although
in the presence of NADH, the efficiency of the superoxide anion photoformation increases two
orders of magnitude, the resulting quantum yield is only several per cents at most. This said,
the efficiency of strongly oxidizing free radicals, such as hydroxyl radical for inducing peroxi-
dation of unsaturated lipids or proteins could be significantly higher than that of singlet oxy-
gen. This is because such a process proceeds via a free radical chain reaction mechanism, in
which the initial oxidative damage is propagated via secondary reactions involving carbon-cen-
tered radicals and oxygen molecules in their ground state [54]. Hydroxyl radicals are formed
during processes, such as the metal ion-catalyzed free radical decomposition of hydrogen per-
oxide, which is the product of superoxide anion dismutation [54]. The photodynamic mecha-
nism of yeast killing mediated through imidazacridinones might be similar to that of
fullerenes, which show relatively low efficiency as photosensitizers operating via type II photo-
chemistry [55]. Indeed, type I photoreactions might be as effective as type II, and possibly even
more effective in antimicrobial PDI [56]. For some groups of photosensitizing compounds
such as thiazins, xanthenes or acridines, it has been shown that oxygen radicals, primarily su-
peroxide anions, were generated [57]. Accordingly, we detected superoxide anion production
through imidazoacridinones. As one of the products of imidazoacridinone photoactivation the
superoxide anion can easily dismutate to form more stable hydrogen peroxide in aqueous
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solutions. Hydrogen peroxide can decompose in a free radical process to create the most reac-
tive oxygen species (ROS), hydroxyl radical. The presence of these ROS might be responsible
for the efficacy of imidazaocridinones photokilling.
Here, we have characterized for the first time the mechanism underlying IA action against
C. albicans. We have shown that structurally different imidazoacridinone derivatives are able
to inactivate C. albicans cells in light dependent manner. Moreover, we provide indications
that fluence rate should be considered as a crucial parameter to improve efficiency of IA-medi-
ated PDI. A correlation between ROS production by particular IA derivative and cell killing
was not observed. Interestingly, we have shown, that IA accumulation and localization events
are critical factors for cell killing, which is in accordance with results obtained for other photo-
sensitizing agents. The results presented here show that IA not only efficiently accumulate in
cells but importantly they are not actively expelled from C. albicans cells via CaCDR1 ABC
transporter. Therefore, IA are promising candidates for the long-term treatment of localized
infections. Overall, this study contributes to a better understanding of the mode of action of
imidazoacridinones, and suggests that these compounds are potential reagents for the photo-
killing of C. albicans.
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